Edition:
India

Insulet Corp (PODD.OQ)

PODD.OQ on NASDAQ Stock Exchange Global Select Market

76.73USD
16 Feb 2018
Change (% chg)

$-0.02 (-0.03%)
Prev Close
$76.75
Open
$76.25
Day's High
$77.34
Day's Low
$76.25
Volume
83,740
Avg. Vol
175,204
52-wk High
$78.61
52-wk Low
$38.43

Latest Key Developments (Source: Significant Developments)

Ascensia Diabetes Care Enters Strategic Alliance With Insulet Corp
Tuesday, 9 Jan 2018 

Jan 9 (Reuters) - ASCENSIA DIABETES CARE::ASCENSIA DIABETES CARE EXPANDS STRATEGIC ALLIANCE WITH INSULET CORPORATION BY SIGNING COMMERCIAL AGREEMENT.ASCENSIA DIABETES CARE - RECIPIENTS OF OMNIPOD DASH WILL RECEIVE CONTOURNEXT ONE METER, CONTOUR NEXT TEST STRIPS PACKAGED WITH INSULIN PUMP.ASCENSIA DIABETES CARE - UNDER TERMS OF NON-EXCLUSIVE COMMERCIAL AGREEMENT, INSULET WILL DISTRIBUTE CONTOUR NEXT ONE BGMS WITH OMNIPOD DASH.  Full Article

Insulet announces pricing of convertible senior notes due 2024
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Insulet Corp :Insulet announces pricing of convertible senior notes due 2024.Insulet Corp - ‍priced a private placement of $350 million principal amount of convertible senior notes due 2024​.Insulet Corp - ‍size of offering increased from previously announced $300 million principal amount​.  Full Article

Insulet announces private offering of convertible senior notes
Tuesday, 7 Nov 2017 

Nov 6 (Reuters) - Insulet Corp :Insulet announces private offering of convertible senior notes.Insulet Corp says ‍to offer $300 million principal amount of convertible senior notes due 2024 in a private placement​.Insulet - ‍intends to grant initial purchasers of notes option to buy up to an additional $45 million principal amount of notes​.  Full Article

Insulet Corp reports Q3 loss per share $0.04
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Insulet Corp :Insulet reports third quarter 2017 financial results.Q3 loss per share $0.04.Q3 revenue $121.8 million versus I/B/E/S view $114.4 million.Q3 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S.Sees fy 2017 revenue up 25 percent.Sees fy 2017 revenue $456 million to $459 million.  Full Article

Insulet announces private offering of convertible senior notes
Wednesday, 7 Sep 2016 

Insulet Corp : Insulet announces private offering of convertible senior notes .Insulet Corp says to offer $250 million principal amount of convertible senior notes due 2021 (notes) in a private placement.  Full Article

Insulet Corp reports Q2 loss per share of $0.08 from cont ops
Thursday, 4 Aug 2016 

Insulet Corp : Insulet reports second quarter 2016 financial results . Q2 loss per share $0.08 from continuing operations . Q2 revenue $87.3 million versus I/B/E/S view $81.2 million . Q2 earnings per share view $-0.17 -- Thomson Reuters I/B/E/S . Sees revenue guidance for 2016 in range of $345 to $355 million .FY2016 revenue view $337.4 million -- Thomson Reuters I/B/E/S.  Full Article

Insulet Corp reaffirms FY 2016 revenue guidance; gives Q2 2016 revenue guidance
Friday, 29 Apr 2016 

Insulet Corp:For FY 2016, the Company is reaffirming its revenue guidance of $330 to $350 million.For Q2 2016, the Company is introducing revenue guidance in the range of $81 to $84 million.  Full Article

BRIEF-Ascensia Diabetes Care Enters Strategic Alliance With Insulet Corp

* ASCENSIA DIABETES CARE EXPANDS STRATEGIC ALLIANCE WITH INSULET CORPORATION BY SIGNING COMMERCIAL AGREEMENT